Compare NAC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAC | AORT |
|---|---|---|
| Founded | 1998 | 1984 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | N/A | 1993 |
| Metric | NAC | AORT |
|---|---|---|
| Price | $11.91 | $39.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $49.36 |
| AVG Volume (30 Days) | 307.3K | ★ 317.1K |
| Earning Date | 01-01-0001 | 02-12-2026 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $422,646,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | N/A | $10.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $9.32 | $21.97 |
| 52 Week High | $11.21 | $48.25 |
| Indicator | NAC | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 34.89 |
| Support Level | $11.79 | $39.08 |
| Resistance Level | $11.96 | $41.00 |
| Average True Range (ATR) | 0.07 | 1.31 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 59.09 | 16.32 |
Nuveen California Quality Municipal Income Fund is a closed-end fixed income mutual fund that prominently invests in tax-exempt municipal bonds from California. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. Its portfolio mainly includes investment-grade municipal securities of California. The fund targets various sectors such as healthcare, utilities, transportation, and consumer staples.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.